A Novel Calcium-Dependent Protein Kinase 1 Inhibitor Potently Prevents Toxoplasma gondii Transmission to Foetuses in Mouse

Treatments currently used to prevent congenital toxoplasmosis are non-specific of Toxoplasma gondii and have grievous side effects. To develop a more specific and less toxic drug, we have designed SP230, an imidazo[1,2-b]pyridazine salt targeting the Toxoplasma gondii calcium-dependent protein kinas...

Descripción completa

Detalles Bibliográficos
Autores principales: Débare, Héloïse, Moiré, Nathalie, Baron, Firmin, Lantier, Louis, Héraut, Bruno, Van Langendonck, Nathalie, Denevault-Sabourin, Caroline, Dimier-Poisson, Isabelle, Debierre-Grockiego, Françoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307510/
https://www.ncbi.nlm.nih.gov/pubmed/34299478
http://dx.doi.org/10.3390/molecules26144203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307510/
https://www.ncbi.nlm.nih.gov/pubmed/34299478
http://dx.doi.org/10.3390/molecules26144203

Ejemplares similares